Skip to main content
logo
Latigo Biotherapeutics, Inc. (LTGO)
NASDAQ: LTGO · Real-Time Price · USD
12.60
-0.41 (-3.15%)
At close: Nov 6, 2026, 4:00 PM EST
12.57
-0.03 (-0.22%)
After-hours: Nov 6, 2026, 6:57 PM EST

Latigo Biotherapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Cash & Equivalents
401.4169.4417.92
Cash & Short-Term Investments
401.4169.4417.92
Cash Growth
-287.53%-
Prepaid Expenses
5.032.183.25
Restricted Cash
-0.19-
Other Current Assets
-2.02-
Total Current Assets
406.4473.8321.16
Property, Plant & Equipment
1.581.071.41
Other Long-Term Assets
0.430.620.29
Total Assets
408.4675.5222.86

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Accounts Payable
-5.027.07
Accrued Expenses
13.2612.876.73
Current Portion of Leases
1.190.560.39
Other Current Liabilities
--0.25
Total Current Liabilities
14.4518.4514.44
Long-Term Leases
-0.130.46
Other Long-Term Liabilities
0.040.040.04
Total Liabilities
14.4818.6114.93

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Additional Paid-In Capital
-11.464.37
Retained Earnings
--243.13-133.96
Total Common Equity
393.97-231.67-129.6
Shareholders' Equity
393.9756.917.93
Total Liabilities & Equity
408.4675.5222.86

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Total Debt
1.190.690.85
Net Cash (Debt)
400.2268.7517.07
Net Cash Growth
-302.81%-
Net Cash Per Share
38.8581.3825.13
Filing Date Shares Outstanding
37.840.880.68
Total Common Shares Outstanding
37.840.880.68
Working Capital
39255.386.73
Book Value Per Share
10.41-263.71-190.84
Tangible Book Value
393.97-231.67-129.6
Tangible Book Value Per Share
10.41-263.71-190.84
Machinery
-1.31.26
SEC Filings: 10-K · 10-Q